VERTEX PHARMACEUTICALS INC / MA Free Cash Flow 2008-2026 | VRTX
Beta
What is VERTEX PHARMACEUTICALS INC / MA's current free cash flow?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual free cash flow for 2025 was $3.19B, a 504.13% increase from 2024. VERTEX PHARMACEUTICALS INC / MA free cash flow for the quarter ending March 31, 2026 was $1.29B.
What was VERTEX PHARMACEUTICALS INC / MA's free cash flow in 2024?
VERTEX PHARMACEUTICALS INC / MA annual free cash flow for 2024 was $-790.3M, a 123.68% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's free cash flow in 2023?
VERTEX PHARMACEUTICALS INC / MA annual free cash flow for 2023 was $3.34B, a 14.99% decline from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year free cash flow CAGR?
VERTEX PHARMACEUTICALS INC / MA free cash flow grew at a compound annual growth rate (CAGR) of 1.30% from FY2020 to FY2025, going from $2.99B to $3.19B over 5 years.
Free Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+1.3%
FY2020
$2.99B
→
FY2025
$3.19B
080910111213141516171819202122232425
5 years selected
Free Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.19B | +504.1% | 10-K |
| FY2024 | $-790.3M | -123.7% | 10-K |
| FY2023 | $3.34B | -15.0% | 10-K |
| FY2022 | $3.93B | +63.0% | 10-K |
| FY2021 | $2.41B | -19.5% | 10-K |
| FY2020 | $2.99B | +100.4% | 10-K |
| FY2019 | $1.49B | +27.2% | 10-K |
| FY2018 | $1.17B | +57.6% | 10-K |
| FY2017 | $745.5M | +315.2% | 10-K |
| FY2016 | $179.5M | +143.7% | 10-K |
| FY2015 | $-410.7M | +34.2% | 10-K |
| FY2014 | $-624.3M | -457.1% | 10-K |
| FY2013 | $-112.1M | -157.0% | 10-K |
| FY2012 | $196.7M | +80.2% | 10-K |
| FY2011 | $109.1M | +116.2% | 10-K |
| FY2010 | $-673.5M | -49.3% | 10-K |
| FY2009 | $-451.1M | -74.4% | 10-K |
| FY2008 | $-258.7M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →